Case Report: Palopegteriparatide as a novel therapeutic option in pediatric autosomal dominant hypocalcemia type 1 - Top-Institutions - MDSpire

Case Report: Palopegteriparatide as a novel therapeutic option in pediatric autosomal dominant hypocalcemia type 1

  • By

  • Arkadiusz Zygmunt

  • Anna Fedorczak

  • Łukasz Krotowski

  • Anna Łupińska

  • Kinga Sałacińska

  • Agnieszka Gach

  • Michael Mannstadt

  • Renata Stawerska

  • June 17, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Oxford University Hospitals NHS Foundation Trust
    Oxford University Hospitals NHS Foundation Trust

    Oxford, England

    Key Differentiators

    • Pediatrics
    • Endocrinology

  • #2

    Polish Mother’s Memorial Hospital – Research Institute
    Polish Mother’s Memorial Hospital – Research Institute

    Lódz, Poland

    Key Differentiators

    • Pediatrics
    • Genetics

  • #3

    Department of Endocrinology and Metabolic Diseases at PMMH-RI
    Department of Endocrinology and Metabolic Diseases at PMMH-RI

    Lódz, Poland

    Key Differentiators

    • Pediatrics
    • Endocrinology

Original Source(s)

Case Report: Palopegteriparatide as a novel therapeutic option in pediatric autosomal dominant hypocalcemia type 1

  • by Arkadiusz Zygmunt, Anna Fedorczak, Łukasz Krotowski, Anna Łupińska, Kinga Sałacińska, Agnieszka Gach, Michael Mannstadt, Renata Stawerska

  • June 17, 2026

Related Content

Complete radiographic response to immunotherapy in a patient with metastatic anaplastic thyroid cancer – a case report and review of the literature

Medical Oddities: Can a Home Be Preventive Care?

This week’s medical plot twists involved ants, architecture, and auditory hallucinations.

HNF1B-MODY (MODY-5): a rare form of diabetes with multisystemic features–two case reports